Friday Nov 29
Late-Stage Businesses Drive Narrow Moats For CROs
Top-tier clinical research organizations possess strong competitive advantages that should allow them to take an outsize share of the rapidly growing market for outsourced research and development.
New Market Research Report: Covance Inc. (CVD) - Financial and Strategic SWOT Analysis Review
Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations.
Applied Clinical Trials
Covance Central Laboratories and NeoGenomics Enter into Exclusive...
Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials /PRNewswire-FirstCall/ -- Covance Inc. , one of the world's largest and most comprehensive drug development services companies, and NeoGenomics, Inc. , a ... (more)
Collaboration Uses Next-Gen Sequencing for Biosafety Assessments
Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing based biosafety assessments to detect and identify viral contaminants within biologic compounds throughout the lifecycle of the product.
Covance To Present At The Credit Suisse Healthcare Conference
Covance Inc. today announced that it will present at the Credit Suisse Healthcare Conference on Wednesday, November 13, 2013 at 9:30 a.m. .